Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)

The Royal Melbourne Hospital, Parkville

Mt. Sinai School of Medicine, New York

Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), Fairfax

Emory University School of Medicine, Atlanta

University of South Florida, Tampa

Cincinnati Children's Hospital Medical Center, Cincinnati

Azienda Ospedaliero-Universitaria Careggi, Florence

University of Iowa Hospital and Clinics, Iowa City

University of Minnesota Medical Center, Minneapolis

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

University of California, Irvine, Irvine

M.A.G.I.C. Clinic Ltd., Calgary

University Medical Center Hamburg-Eppendorf, Hamburg

University Hospital of Würzburg, Würzburg

National Taiwan University Hospital, Taipei

Royal Free Hospital, London

Queen Elizabeth Hospital, Birmingham

Addenbrooke's Hospital, Cambridge